-
News | 2025.04.09
Collections from the Institut Pasteur museum on display at the Villa du Temps retrouvé in Cabourg
The Pasteur Museum is a partner of the exhibition "Louis Pasteur, the art of science," on display at the Villa du temps retrouvé in Cabourg. The exhibition features 46 cultural works and artifacts, some of which have never been seen by the public before. It focuses on Louis Pasteur's artistic side and also highlights other key figures in the Institut Pasteur's history such as Jean Binot (1867-...
-
News | 2025.04.22
Tecovirimat is an effective treatment for mpox
The antiviral drug tecovirimat is frequently used to treat mpox. But is it really effective, especially against the new, more pathogenic strain of the virus that has been in circulation since 2024? A study by the Institut Pasteur, recently published in The Lancet Infectious Diseases (1), concludes that it is.
-
Article | 2017.01.04
Pasteur-Cnam-EHESP School of Public Health
The Institut Pasteur and the Cnam (National Conservatory of Arts and Crafts), in partnership with the EHESP (French School of Public Health), have combined their complementary expertise within the Pasteur-Cnam-EHESP School of Public Health to offer an Advanced Master degree - Mastère Spécialisé in Public Health.
-
Vidéo | 2025.04.24
Goodbye allergic asthma?
Every spring, the same battle: allergic asthma poisons the lives of millions of people.This form of asthma, triggered by allergens such as pollen, dust mites or animal hair, accounts for around 50% of asthma cases worldwide.As well as causing respiratory discomfort, it has a lasting impact on quality of life, and remains difficult to control, particularly in its severe forms.Today, the treatments...
-
Vidéo | 2025.04.25
How does physics reveal the secrets of life ?
Diving into the invisible: when physics reveals the secrets of life These hypnotic images of dividing bacteria are more than just aesthetic: they are at the heart of research carried out by Gautham Sankara Narayana, a biophysics researcher in the Duménil laboratory at the Institut Pasteur, as part of the Bonazzi team. Using confocal microscopy and computational analysis tools, he is...
-
Article | 2025.02.07
International support
International support is crucial to our success
-
Report | 2024.12.11
The history of mpox: from the very first cases to new findings
The first cases of mpox were observed in the Democratic Republic of Congo in 1970, then spread to a number of other African countries. In the Central African Republic, the first case was recorded in the 1980s, in a family living in the south-west of the country. The Institut Pasteur de Bangui monitored this case and the subsequent ones, and has since developed expertise on the disease,...
-
Article | 2025.04.28
Lettre de l'Institut Pasteur - International
Find all the publication archives of La lettre de l'Institut Pasteur
-
News | 2025.04.29
Advanced HPV RNA-Seq Test developed by the Institut Pasteur : exclusive license signed with ABL Diagnostics
The Institut Pasteur, a Carnot institute since 2007, and ABL Diagnostics, a Euronext-listed leader in molecular diagnostics, recently signed a licensing agreement for the integration of the innovative HPV RNA sequencing technology into ABL Diagnostics solutions, which will produce and market the test.HPV RNA-Seq is a cutting-edge diagnostic method that enhances the detection and typing of high-...
-
Document de presse | 2025.03.31
MOPEVACLAS vaccine candidate for Lassa fever enters clinical trials
After more than 20 years of research on arenaviruses, an Institut Pasteur team led by Sylvain Baize has developed an original vaccine platform known as MOPEVAC, which will strengthen the Institut Pasteur's pandemic preparedness initiatives. A Phase Ia clinical trial led by a research team at the Institut Pasteur is set to begin for the platform's first vaccine candidate, which targets Lassa fever...
